Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

557 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.
Sinha A, Klebe R, Rekart ML, Alvarez JL, Skrahina A, Yatskevich N, Solodovnikova V, Viatushka D, Parpieva N, Safaev K, Liverko I, Tigay Z, Moe S, Khristusev A, Allamuratova S, Mirzabaev S, Achilov M, Samieva N, Lachenal N, Merle CS, Sall FB, Restrepo CG, Tan C, Sitali N, Saunders MJ. Sinha A, et al. Clin Infect Dis. 2025 Nov 6;81(4):838-845. doi: 10.1093/cid/ciaf035. Clin Infect Dis. 2025. PMID: 39964841 Free PMC article.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators. Nyang'wa BT, et al. N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166. N Engl J Med. 2022. PMID: 36546625 Clinical Trial.
Primary bedaquiline resistance in Karakalpakstan, Uzbekistan.
Moe S, Rekart ML, Hernandez D, Sholpan A, Ismailov A, Oluya M, Bayniyazova A, Zinaida T, Nargiza P, Gomez-Restrepo C, Sitali N, Sinha A. Moe S, et al. Int J Tuberc Lung Dis. 2023 May 1;27(5):381-386. doi: 10.5588/ijtld.22.0536. Int J Tuberc Lung Dis. 2023. PMID: 37143220 Free PMC article.
A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020.
Rekart ML, Thit P, Oluya M, Moe S, Hasan T, Parpieva N, Safaev K, Khristusev A, Zinaida T, Singh J, Allamuratova S, Azamat I, Restrepo CG, Sitali N, Achar J, Alvaraez JL, Sinha A. Rekart ML, et al. IJTLD Open. 2024 Jul 1;1(7):285-291. doi: 10.5588/ijtldopen.23.0533. eCollection 2024 Jul. IJTLD Open. 2024. PMID: 39035427 Free PMC article.
Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan.
Moe S, Azamat I, Allamuratova S, Oluya M, Khristusev A, Rekart ML, Mamitova K, Bidwell G, Gomez-Restrepo C, Kalmuratov B, Tigay Z, Parpieva N, Safaev K, Sitali N, Gomez D, Mikhail A, Sinha A. Moe S, et al. IJTLD Open. 2024 Sep 1;1(9):391-397. doi: 10.5588/ijtldopen.24.0351. eCollection 2024 Sep. IJTLD Open. 2024. PMID: 39301133 Free PMC article.
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation.
Sweeney S, Laurence YV, Berry C, Singh MP, Dodd M, Fielding K, Kazounis E, Moodliar R, Solodovnikova V, Tigay Z, Liverko I, Parpieva N, Butabekov I, Usmanova R, Rassool M, Motta I, Nyangweso GM, Jolivet P, Abdrasuliev T, Moe S, Aw PS, Samieva N, Nyang'wa BT. Sweeney S, et al. Lancet Glob Health. 2025 Feb;13(2):e355-e363. doi: 10.1016/S2214-109X(24)00467-4. Lancet Glob Health. 2025. PMID: 39890235 Free article.
Yield of TB screening in prisons in Tajikistan.
Moe S, Asozoda M, Aung A, Dusmatova Z, Akintore F, Nshimiyimana E, Zavqibekov A, Sitali N, Mulanda WK, Cullip T, Sinha A. Moe S, et al. IJTLD Open. 2024 Aug 1;1(8):344-348. doi: 10.5588/ijtldopen.24.0272. eCollection 2024 Aug. IJTLD Open. 2024. PMID: 39131592 Free PMC article.
Characteristics, Treatment Strategies, and Long-term Health Outcomes of People With Bedaquiline-resistant Tuberculosis in Karakalpakstan, Uzbekistan-A Retrospective Cohort Study.
Saunders MJ, Garsevanidze E, Allamuratova S, Cholakyans V, Sharma J, Ismailov A, Gomez D, Rekart ML, Nair P, Moe S, Tigay Z, Parpieva N, Safaev K, Gomez-Restrepo C, Sitali N, Alvarez JL, Sinha A. Saunders MJ, et al. Among authors: moe s. Open Forum Infect Dis. 2026 Jul 20;13(7):ofag405. doi: 10.1093/ofid/ofag405. eCollection 2026 Jul. Open Forum Infect Dis. 2026. PMID: 42517152 Free PMC article.
The effect of dietary fiber based on fermentability and viscosity on the gut microbial metabolites in chronic kidney disease: a systematic review and meta-analysis of experimental and clinical trials.
Mirmohammadali SN, Carrillo C, Reed JB, Kistler BM, Wilson HE, Hamaker B, Moe SM, Biruete A. Mirmohammadali SN, et al. Among authors: moe sm. medRxiv [Preprint]. 2026 Jul 10:2026.07.09.26357677. doi: 10.64898/2026.07.09.26357677. medRxiv. 2026. PMID: 42465891 Free PMC article. Preprint.
Europe's bottlenecks to the operationalisation of Essential Biodiversity Variables for Environmental Policy Support.
Morán-Ordóñez A, Blasi M, Santana J, Beja P, Breeze TD, Carvalho L, Cardoso AC, Fraixedas S, Gargallo G, Gervasini E, Herrando S, Jiménez Alfaro B, Junker J, Kissling WD, Kovacevic V, Langendoen T, López-Baucells A, Lumbierres M, Lyche Solheim A, Magliozzi C, Mentzel S, Miret-Minard G, Moe SJ, Moreira F, Pavón-Jordán D, Pereira HM, Potts SG, Shamoun-Baranes J, van Grunsven RHA, Villero D, Brotons L. Morán-Ordóñez A, et al. Among authors: moe sj. NPJ Biodivers. 2026 Jul 9. doi: 10.1038/s44185-026-00147-4. Online ahead of print. NPJ Biodivers. 2026. PMID: 42420478 Free article.
557 results